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Oral healthThe plaque inhibiting properties of magnolia bark extract (MBE) were assessed in a volunteer trial follow-
ing the consumption of various sugar-free chewing gum formulations over a period of 4-days. Paired t-
tests demonstrated significant (p < 0.15) differences between the placebo and a gum containing MBE
(0.4%) plus lauramide arginine ethyl ester (LAE) (0.5%) with respect to% plaque coverage (36.3% vs
34.0%) and area of plaque fluorescence (109.4 mm2 vs 75.2 mm2). These findings were supported by
microbiological counts of total salivary bacteria (7.77 log10 cfu/ml vs 7.45 log10 cfu/ml) as well as
Streptococcus spp. (6.76 log10 cfu/ml vs 6.29 log10 cfu/ml). MBE (0.4%) + LAE (0.5%) delivered by chewing
gum had a moderate inhibitory effect on plaque formation and salivary bacteria. Limiting the formation
of dental plaque and salivary bacteria, specifically oral streptococci, could contribute towards an
improvement in oral health with respect to gum disease and caries.
 2017 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
A panoply of phytochemicals have received interest on account
of their potential pharmacological or antimicrobial activity (Abreu,
McBain, & Simoes, 2012), including those purported to be active
against oral bacteria (Ciric et al., 2011). Magnolia Bark Extract
(MBE) is one such natural product from the stem bark of Magnolia
officinalis (Magnoliaceae) that is isolated by CO2 super critical fluid
extraction (Modey, Mulholland, & Raynor, 1996). MBE is actually a
mixture of neolignans, lignans, alkaloids and sesquiterpenes (Shen
et al., 2009), including over a dozen polar molecules (Yu, Yan,
Liang, Wang, & Yang, 2012); but its primary components(45–97%) are magnolol [4-Allyl-2-(5-allyl-2-hydroxy-phenyl)phe
nol] and its isomer honokiol [2-(4-hydroxy-3-prop-2-enyl-
phenyl)- 4-prop-2-enyl-phenol] (Fig. 1). Both magnolol and hono-
kiol are potent antioxidants (Lo, Teng, Chen, Chen, & Hong, 1994)
that have demonstrable broad spectrum antimicrobial activity
against a number of different (non-oral) bacteria (Hu, Qiao,
Zhang, & Ge, 2011; Park et al., 2004) as well as some fungi, includ-
ing Candida albicans (Bang et al., 2000). Magnolol has also been
shown to specifically inhibit biofilm formation in Staphylococcus
aureus (Wang et al., 2011). With regard to the oral microbiota,
MBE has an antimicrobial effect against a number of periodonto-
pathic bacteria including Porphyromonas gingivalis, Prevotella spp.,
Aggregatibacter actinomycetemcomitans and Capnocytophaga
gingivalis (Chang, Lee, Ku, Bae, & Chung, 1998; Ho, Tsai, Chen,
Huang, & Lin, 2001) as well as bacteria associated with dental car-
ies including Streptococcus mutans (Namba, Hattori, Tsunezuka,
Yamagishi, & Konishi, 1982). Furthermore, MBE has been reported
to exhibit anti-quorum sensing activity against non-oral bacteria
Fig. 1. Magnolol and honokiol.
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2012). MBE is a traditional Chinese medicine permitted food addi-
tive and is classified as ‘generally regarded as safe’ (GRAS) by the
United States Food and Drug Administration following indepen-
dent recommendation (Li et al., 2007; Liu et al., 2007), and has also
received Novel Foods Approval status in the European Union (EC
258/97, Article 4.2). The antimicrobial effect of MBE has been
recently attributed to magnolol and honokiol’s ability to bind to
surface appendages of the microbial cell, most notably of gram-
negative bacteria, whereby they increase cell surface hydrophobic-
ity (Wessel et al., 2016).
The antimicrobial properties of MBE suggest that it may be able
to moderate the growth of oral bacteria and if such activity can be
manifested in the mouth it could in turn contribute towards an
improvement in oral health (American Academy of
Periodontology. Research, 2005). One possible method of deliver-
ing antiplaque actives into the oral cavity is in a form of chewing
gum (Simons, Kidd, Beighton, & Jones, 1997; Smith, Moran,
Dangler, Leight, & Addy, 1996). However, the hydrophobic nature
of magnolol and honokiol means that these molecules are only
slightly water soluble, and as such they do not release well in an
aqueous environment such as saliva from chewing gum. Work in
the sponsor’s laboratory suggests that approximately 50% of the
loaded dose of MBE is released from the gum matrix over a 20-
min chew period due to of the solubility limit of the active agents
in saliva. The aim of this plaque regrowth experiment was to test
MBE at a concentration of 0.4% with an expected delivery dose of
6 mg per gum serving and also in combination with lauramide
arginine ethyl ester (LAE) as a surfactant to help release and dis-
perse MBE in the oral environment. LAE is approved as a food addi-
tive by the European Food Safety Authority (EFSA-Q-2006-035)
and the United States Food and Drug Administration (GRAS
000164).
A well-established, plaque regrowth protocol has been widely
used to compare the effects of a range of oral interventions; includ-
ing mouthwashes, toothpastes and chewing-gums containing;
chlorhexidine, triclosan, probiotics and essential oils (De Siena,
Del Fabbro, Corbella, Taschieri, & Weinstein, 2013; Keller,
Hasslof, Dahlen, Stecksen-Blicks, & Twetman, 2012; Pizzo,
Compilato, Di Liberto, Pizzo, & Campisi, 2013; Pizzo et al., 2007;
Pretty, Edgar, & Higham, 2004). Such plaque regrowth studies, by
definition, require the implementation of plaque planimetric tech-
niques – one of which is quantitative light-induced fluorescence
(QLF). This technique uses 405 nm light to induce red fluorescence
in dental plaque (de Josselin de Jong, Higham, Smith, van Daelen, &
van der Veen, 2009). The aim of this plaque regrowth study was to
use QLF and microbiological techniques to determine if MBE con-
taining chewing gums have any plaque inhibiting properties.2. Materials and methods
2.1. Clinical trial
This clinical trial was a single-centre, double-blind, single-
treatment, randomised, placebo-controlled, four-legged crossovertrial taking place over a period of 8 weeks involving 12 subjects.
The sequence of sugar-free gum (SFG) formulations allocation
was predetermined using a Latin Square (Varma, Fertig, Chilton,
& Mandel, 1974). Twelve healthy adult volunteers (aged 19–63)
were recruited from staff and postgraduate students working at
the Liverpool University Dental Hospital. Ethical approval was
sought from the local ethics committee (Liverpool Adult Research
Ethics Committee, reference number 09/H1005/45). All of the vol-
unteers received verbal and written information concerning the
study and informed written consent was taken. A washout period
of 9 days preceded each experimental phase. At the beginning of
each leg of the study (Monday morning) the subjects were given
professional tooth-cleaning by a dentist after their teeth had been
disclosed using PlaqueFinderTM (Pro-Dentec, Rota-Dent, Cambridge,
UK). Baseline white-light digital images and QLF images were
taken to confirm that the labial surfaces of the anterior teeth (max-
illary and mandibular, canine to canine; 11–13, 21–23, 31–33, 41–
43) were plaque free.
2.2. Chewing gum formulations and dosage
The exact methods used in preparing the gum by the manufac-
turer are proprietary, although they can be summarised here in
brief. Due to its extreme hydrophobicity, MBE (Honsea Sunshine
Bioscience and Technology Co., Ltd., Guangzhou, China) containing
95.42% magnolol and 1.94% honokiol (manufacturer’s data; as
determined by high-performance liquid chromatography) was
added to the pellet coating, along with flavouring and LAE (as
appropriate) rather than incorporating this into the gum core.
The subjects were provided with SFG containing one of the
three test formulations or a placebo in the form of chewing gum
in 5 heat sealed bags (each containing 10  1.5 g gum pellets),
one for each day Monday through Friday. The volunteers were
asked to self-administer a serving of two pellets, five times per
day in the absence of other oral hygiene procedures. The chewing
gum was consumed over a period of 10 min at unspecified time
points spread as evenly as possible throughout the day. The four
SFG formulations, used in the study were; placebo gum (winter-
green flavour), MBE (0.4%), MBE (0.4%) plus LAE (0.5%) and MBE
(0.4%; suck-then-chew method). The ‘suck-then-chew’ method
denoted specific instructions to the subjects to suck the gum pel-
lets for the first 2 min followed chewing for the remaining 8 min.
The subjects were provided with a generic stopwatch timer to
ensure adherence to these protocol.
2.3. Microbiological sampling and analysis
After the end of each experimental leg (Friday afternoon) the
subjects returned to the dental clinic. Firstly, the subjects were
asked to drool saliva (i.e. unstimulated) over a period of 5 min into
a sterile container. After collection, the saliva sample was placed
into a container of crushed ice and immediately transported from
the clinic to the laboratory for processing within 10 min of collec-
tion. The saliva samples were vortex mixed and then serially
diluted in phosphate-buffered saline (Oxoid, Basingstoke, UK).
20 ml aliquots of these dilutions were then spread in quadruplicate
onto fastidious anaerobic agar (FAA) containing 5% defibrinated
horse blood (TCS Biosciences, Buckingham, UK) as a non-selective
solid growth medium (Lab M, Heywood, UK). Replicate aliquots
were similarly spread onto Mitis salivarius agar (MSA) supple-
mented with 1% Chapman tellurite (Beckton Dickinson, Oxford,
UK) to isolate the growth of Streptococcus spp. All of these plates
were then incubated at 37 C under anaerobic conditions (80%
N2, 10% CO2, 10% H2) for 72 h before the number of colony forming
units (cfu) was determined. The cfu results were log10 transformed
prior to statistical analysis by t-test (paired samples for means).
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Dental plaque was disclosed after saliva donation and a second
set of QLF images was captured. The subjects were then provided
with further dental prophylaxis before undergoing a nine day
washout period during which they resumed their normal oral
hygiene procedures using the toothbrush and toothpaste (Tesco
Daily Care 1090 ppm F, Cheshunt, UK) provided as part of this
study. They were then asked to present the following Monday for
the next phase of the trial. This was repeated until each subject
has used all four SFG formulations. Subjects followed their usual
diet including any regular snacks they normally consumed in the
course of a day.
The QLF images were analysed using proprietary software
(InspektorProTM; Inspektor Research Systems BV, The Netherlands)
which incorporates tools for measuring the intensity of red fluores-
cence (DR) in comparison to a plaque-free reference region of the
tooth. The software also returned the area of red fluorescence
(mm2). These analyses were performed for each of twelve images
of the anterior teeth and used to calculate an average for each indi-
vidual volunteer. The images were also analysed using freely avail-
able image analysis software (ImageJ v1.43; National Institutes of
Health, Bethesda, USA) to calculate the percentage of the tooth
covered with plaque. Briefly, the QLF image was split into its com-
ponent colours to isolate the green and the red colour channels.
These two, 8-bit greyscale images (0–255; 0 = black, 255 = white)
were then processed by the ‘Image Calculator’ function to divide
the red pixel values by the green pixel values. The total number
of pixels within the area of the tooth was used to calculate the per-
centage plaque coverage by allocating pixels with a value of ‘0’ as
‘plaque-free’ and those with a value 1 as ‘plaque covered’. The
superimposition of a number of representative original images
with the binary results of the image calculator showed good con-
formity and reproducibility for this technique (Hope et al., 2014).2.5. Statistical analysis
Three planimetric methods were used to assess plaque re-
growth. The intensity of red fluorescence (DR%) and the area of
red fluorescence (mm2) were assessed by QLF, whereas the per-
centage area of disclosed dental plaque was determined by image
analysis. The planimetric analyses were supported by two microbi-
ological analyses of the total number of viable bacteria and strep-
tococci present in volunteers’ saliva. The sample size was twelve in
all instances.
The alpha level of significance used in the planimetric and
microbiological analyses was set at p < 0.15 to detect a ‘moderate
effect’ as delivered by a functional foodstuff as opposed to a
‘clinically significant’ effect at p < 0.05 that one would perhaps
wish to achieve from a medicament.Fig. 2. Box plots of plaque planimetrics; percentage of red fluorescence (DR%), area
of red fluorescence (mm2) and percentage plaque coverage (%) following consump-
tion of various chewing gum formulations; placebo, MBE (0.4%), MBE (0.4%) + LAE
(0.5%) and MBE S > C (0.4%) consumed by sucking for two minutes before chewing.
* Indicates p < 0.15 (ANOVA, n = 12).3. Results
3.1. Plaque planimetrics
Analysis of variance (ANOVA) revealed a statistically significant
‘moderate effect’ (i.e. p < 0.15) between experimental groups in
terms of DR% and area of red fluorescence (mm2) (p = 0.07)
(Fig. 2). Paired t-tests for post hoc comparisons demonstrated sig-
nificant differences between the placebo gum (36.3%) and MBE
+ LAE (34.0%) (p = 0.08). A stronger significance was observed with
respect to the area of red fluorescence (ANOVA; p = 0.04), whilst
the corresponding paired t-test showed significance between the
placebo gum (109.4 mm2) and MBE + LAE (75.2 mm2) (p = 0.03)
(Fig. 2). The image analysis methods to calculate percentage
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between the SFGs (ANOVA; p = 0.76).3.2. Salivary microbiology
The log10 mean counts of total salivary bacteria enumerated as
colony forming units per millilitre on FAA, revealed significant dif-
ferences between the four SFG formulations (ANOVA; p = 0.046)
(Fig. 3). Paired t-tests revealed that the difference between placebo
(7.77 log10 cfu/ml) and MBE + LAE (7.45 log10 cfu/ml) was signifi-
cant (p = 0.046). Likewise, the log10 mean counts of Streptococcus
spp. as enumerated on MSA revealed a similar trend (ANOVA;
p = 0.135) together with a significant difference between placebo
(6.76 log10 cfu/ml) and MBE + LAE (6.29 log10 cfu/ml) (p = 0.066).Fig. 3. Box plots of salivary microbiology; counts of total viable bacteria and
streptococci (log10 cfu/ml) following consumption of various chewing gum formu-
lations; placebo, MBE (0.4%), MBE (0.4%) + LAE (0.5%) and MBE S > C (0.4%)
consumed by sucking for two minutes before chewing. * Indicates p < 0.15 (ANOVA,
n = 12).3.3. MBE + LAE
Overall, the mean values for all five measurements of plaque
regrowth demonstrated lower values in the MBE + LAE leg of the
experiment compared to the placebo gum. These differences were
significant (p < 0.15) in all instances with the exception of percent-
age plaque coverage (Fig. 4 and Table 1). A similar result was found
when comparing the MBE (0.4%) vs MBE (0.4%) + LAE in that the
addition of the surfactant had a statistically significant (p < 0.15)
effect in reducing plaque indices by all measures with the excep-
tion of percentage plaque coverage (Table 1).
4. Discussion
The described protocol is based upon a well-established
methodology for assessing plaque regrowth which has sufficient
power to discriminate at the alpha = 0.15 level with a sample size
of twelve volunteers (Moran, Addy, & Newcombe, 1997; Pretty,
Gallagher, Martin, Edgar, & Higham, 2003). Although in vitro
experiments are useful for screening possible antimicrobial
agents and determining their minimum inhibitory concentrations
(MIC), plaque regrowth studies such as these are more represen-
tative of adjunct oral hygiene measures that might be taken
throughout the day, such as chewing SFG or sucking sugar-free
confectionary.
Magnolol and honokiol are highly hydrophobic and relatively
insoluble with a log P (partition coefficient; a measure of solubil-
ity) of 5.25 (details provided by the sponsor’s laboratory). This pre-
sents a challenge when it comes to dispersing these adjuncts in
saliva. It was for this reason that the surfactant LAE was included
in one of the gum formulations as was the ‘suck-then-chew’ vari-
able. The results suggest that sucking the active ingredient-
containing coating did not measurably enhance the effects of
MBE, probably because this approach did nothing to address the
problem of hydrophobicity/solubility. However, the inclusion of
the surfactant LAE did significantly increase the efficacy of MBE
when compared to MBE alone (Table 1).
A previous study involving chewing sugar-free gum for a period
of twenty minutes elicited an increase in subjects salivary flow rate
from a baseline of 0.6 ml min1 to a peak of 5.3 ml min1 and con-
tinued to be stimulated at a rate of 1.6 ml min1 at the cessation of
chewing. This study also revealed that there was also a correspond-
ing increase in salivary pH of approximately 0.5 units during chew-
ing together with an immediate increase in sodium concentration
from 5.8 mmol l1 to 32.3 mmol1 which then fell to 11.6 after
twenty minutes (Dawes & Dong, 1995). The ecological plaque
hypothesis (Marsh, 2003) proposes that such changes in saliva
composition, being part of the plaque’s ‘local environment’, could
potentially bring about a corresponding shift in the plaque’s micro-
bial composition. However a more likely cause for changes in pla-
que composition upon exposure to a (phyto)chemical agent would
be due to the selective inhibition (or enrichment) of certain bacte-
rial species. Subtle changes in specific members of the oral micro-
biota can elicit much larger dynamic shifts in the microflora on the
whole (Hajishengallis et al., 2011; Marsh, Head, & Devine, 2015).
A recent study into the effects of sugar-free chewing gum con-
taining MBE corroborates our findings by reporting a reduction in
salivary mutans streptococci (Campus et al., 2011). There were
however a number of important differences in the experimental
designs between their study and the present study. Firstly,
although they used a much larger sample size (n = 120) they did
not employ a cross-over design (n = 38–40 per group). Secondly,
the active dose was lower as the gum contained 0.17% MBE, with-
out the addition of a surfactant, and was taken as five pieces, three
times a day for 30 days. Thirdly, they enumerated mutans strepto-
cocci on Mitis salivarius agar supplemented with bacitracin; as a
Fig. 4. Plaque indices; DR (%), area of red fluorescence (mm2), percentage plaque coverage (%) and numbers of viable bacteria (log10 cfu/ml; total bacteria and Streptococci)
for the different gum formulations; placebo, MBE (0.4%), MBE (0.4%) + LAE (0.5%) and MBE S > C (0.4%) consumed by sucking for two minutes before chewing. * and + symbols
indicate statistical significance; *p < 0.15; (t-test paired samples, n = 12).
Table 1
Summary of the mean values (n = 12) of plaque indices and viable counts of bacteria with respect to plaque regrowth following consumption of four different chewing gum
formulations.








Placebo 36.29 109.40 36.02 7.77 6.76
MBE (0.4%) 37.16 117.48 36.50 7.77 6.51
MBE (0.4%) + LAE (0.5%) 34.01 75.16 32.53 7.45 6.29
MBE (0.4%); suck then chew 35.94 113.85 37.62 7.72 6.56
ANOVA P-value 0.073 0.041 0.738 0.136 0.135
Placebo vs MBE (0.4%) + LAE (0.5%) 0.080 0.026 0.260 0.046 0.066
MBE (0.4%) vs MBE (0.4%) + LAE (0.5%) 0.005 0.007 0.225 0.022 0.070
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of 1.5 log lower than the present study which reported total strep-
tococci. Perhaps most importantly though, the Campus study was
not a ‘plaque re-growth’ study in that the volunteers continued
with their existing oral hygiene measures in the form of a stan-
dardised fluoridated (1450 ppm) toothpaste. Other interesting
findings of the study were that MBE elicited a reduction in the aci-
dogenicity of plaque together with a reduction in bleeding score.
These findings corroborate those reported in a study which
reported that 0.2% MBE delivered in the form of chewing gum or
pressed mints reduced levels of salivary bacteria (Greenberg,
Urnezis, & Tian, 2007). The Greenberg study also challenged a
panel of three oral bacteria; Porphyromonas gingivalis, Fusobac-
terium nucleatum and S. mutans with MBE and reported MICs of
8, 31 and 16 mg/ml respectively. A more recent laboratory study
reported that a methanol extract of magnolia bark had an MIC
against planktonic S. mutans of 30 mg/ml whilst the purported
antimicrobial components, magnolol and honokiol, both had an
MIC of 10 mg/ml (Sakaue et al., 2016). This study also demonstrated
an antibiofilm effect although a minimum biofilm eradication con-
centration was not given. The ability of MBE to increase cell surface
hydrophobicity causes the affected bacteria to form larger cell
aggregates (Krasowska & Sigler, 2014) that would be less likely
to be incorporated into the existing plaque mass by co-
aggregative mechanisms than smaller aggregate/individual cells.Future work should seek to determine the effects that MBE and/
or its components have upon a developing multispecies biofilm
community either by using complex in vitro models (Hope et al.,
2012) or expanded in vivo studies.5. Conclusions
The results of the present study suggest that MBE (0.4%) + LAE
(0.5%) delivered by chewing gum under the regimen described
above had a significant inhibitory affect upon plaque formation.
MBE without surfactant (LAE) did not have a plaque-inhibiting
effect which suggests that the surfactant improved the bioavail-
ability of the MBE components. The regular consumption of an
MBE containing chewing gum between toothbrushings could pos-
sibly contribute towards good oral health.
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